Literature DB >> 3574589

Reconstitution of solubilized atrial cholinergic muscarinic receptors in liposomes.

J S Aguilar, E L Ochoa, E De Robertis.   

Abstract

The reconstitution of solubilized bovine atrial cholinergic muscarinic receptor into liposomes made of exogenous lipids has been achieved by polyethyleneglycol precipitation. Of the different lipid mixtures used, soybean lecithins were shown to be the best on the basis of receptor recovery. The receptor reconstituted into soybean lecithins liposomes exhibited ligand binding properties very similar to those of the native receptor. The dissociation constant of [3H]-N-methyl-scopolamine ([3H]NMS) was 0.46 and 0.30 nM as determined by equilibrium and kinetics experiments respectively. The potency of a range of muscarinic ligands in displacing [3H]NMS binding was atropine greater than methyl-atropine greater than scopolamine greater than pirenzepine oxotremorine greater than gallamine greater than carbamylcholine greater than pilocarpine bethanechol. The Hill slopes of the displacement curves were near 1 for the antagonists and smaller than 1 for the agonists and for gallamine. The agonist binding may be modulated by guanine nucleotides. These results indicate that soybean lecithins fulfill the lipid requirements for the reconstitution of the atrial muscarinic receptor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3574589     DOI: 10.1007/bf00971369

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  49 in total

1.  The heterogeneity and nucleotide modulation of cholinergic muscarinic receptors are restored by poly (ethylene) glycol-6000 precipitation of solubilized atrial receptors.

Authors:  J S Aguilar; E L Ochoa
Journal:  Neurochem Int       Date:  1986       Impact factor: 3.921

Review 2.  Inositol phospholipids and cell surface receptor function.

Authors:  R H Michell
Journal:  Biochim Biophys Acta       Date:  1975-03-25

Review 3.  Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties.

Authors:  G A Weiland; P B Molinoff
Journal:  Life Sci       Date:  1981-07-27       Impact factor: 5.037

4.  Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.

Authors:  M Waelbroeck; P Robberecht; P Chatelain; J Christophe
Journal:  Mol Pharmacol       Date:  1982-05       Impact factor: 4.436

5.  Solubilization of the atrial muscarinic acetylcholine receptor: a new detergent system and rapid assays.

Authors:  C R Cremo; G S Herron; M I Schimerlik
Journal:  Anal Biochem       Date:  1981-08       Impact factor: 3.365

6.  Agonist-antagonist interactions with rat atrial muscarinic cholinergic receptor sites: differential regulation by guanine nucleotides.

Authors:  J W Wei; P V Sulakhe
Journal:  Eur J Pharmacol       Date:  1979-09-01       Impact factor: 4.432

7.  Agonists differentiate muscarinic receptors that inhibit cyclic AMP formation from those that stimulate phosphoinositide metabolism.

Authors:  J H Brown; S L Brown
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

8.  Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.

Authors:  J H Lee; E E el-Fakahany
Journal:  J Pharmacol Exp Ther       Date:  1985-06       Impact factor: 4.030

9.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

10.  Muscarinic cholinergic receptor structure. Receptor size, membrane orientation, and absence of major phylogenetic structural diversity.

Authors:  J C Venter
Journal:  J Biol Chem       Date:  1983-04-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.